⚡️San Raffaele HSR Arrhythmology Journal Club⚡️
- Director: Dr. Paolo Della Bella
- When: once per month, Thursday, 5 PM (CET)
- Where: Zoom (link in description)
- What: VT (Dr. C. Bisceglia), AF/SVT (Dr. M. Cireddu), ICD/PM (Dr. P. Mazzone), CMP & SCD (Dr. G. Peretto)
Probably love in EP starts with accessory pathways. Very small discrete structures producing big changes in the ECG. One shot ablation can be curative.
Today ablation of a left AP in a 12 yrs old girl, by Dr. Gulletta in @SRArrhythmology
ARVD pt with VTs.
Today epi-endo VT ablation by Dr Bisceglia -Radinovic & @OnishiYoshimi … Mesmerizing VT interruption during RF.
1- sinus ilam
2-vt egm
3-vt lat map
4-first rf
@alebelletti1 was leading the anaesthesiologist team. 😴
@SRArrhythmology@ivroca@DrRoderickTung
We are proud to announce that our research project GEAM: yield of GEnetic testing in Arrhythmic Myocarditis, led by Dr. Giovanni Peretto, was funded with the Early Career Award by Fondazione Regionale per la Ricerca Biomedica (FRRB) and Regione Lombardia. https://t.co/CC68Vt6Dvy
Even though these maps are getting mesmerizing, VT interruption is driven by visual #VEDUM point termination during ongoing VT.
4 sec to affect the slowest area inside a huge VT isthmus.
EGM duration = slow conduction
@BiosenseWebster
#òpurpo@CerrutoGiuliano@PietroRossiEP
We explored pentraxin 3 (PTX3), an acute phase protein, as a potential biomarker in plasma and cardiac biopsies of patients with myocarditis.
#myocarditis
https://t.co/0MecZhOAJl
A nice review of recent years in ablation research-Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward https://t.co/KcrcKR430R
A very important study. Inflammation in the heart, in the context of LV dysfunction, cannot be a good thing. More data is needed, but this study gives us some light #cardiacimmunology
🍺🇮🇹🪖finally out in @CirculationEP ! #Vedum for substrate mapping. Ventricular Electrograms Duration Map to Detect Ventricular Arrhythmia Substrate: the VEDUM Project Study | Circulation: Arrhythmia and Electrophysiology https://t.co/GWYVfvKIs3
Use of multimodal imaging in genetic cardiomyopathies may allow for the identification of myocardial inflammation potentially responsive to immunomodulatory therapy.
Read the new #JACCBTS study by @GiovanniPeretto et al here: https://t.co/SYKiUPyz19
#HeartFailure#CardioRheum
Our new pilot report of 25 patients with genetic cardiomyopathy and biopsy-proven myocardial inflammation. M-Infl was characterized by multimodal imaging, including CMR and PET, and treated with immunomodulatory therapy for the first time in NGS+ patients. https://t.co/XvdGQa4DqF
Functional characterisation of the rare SCN5A p.E1225K variant, segregating in a Brugada syndrome familial case, which caused an impairment of the mutated Nav1.5 in human cardiomyocytes from pluripotent stem cells.
https://t.co/usGmEyGPRD
From bedside to the bench, the role of myocardial inflammation (M-Infl) is emerging in the pathophysiology, phenotype, and treatment of traditionally genetic cardiomyopathies (DCM/ACM). Check our "hot off the press" review!
https://t.co/RyycCYdKf6